Evidence map›Paper›PMID 40176052›Full record

ArticleInternational journal for equity in health2025

Pacific community's perceptions on how to improve uptake of urate-lowering therapy for Pacific gout patients.

Samuela Ofanoa, Malakai Ofanoa, Siobhan Tu'akoi, Hinamaha Lutui, Maryann Heather, Felicity Goodyear-Smith

Abstract read
In one paragraph

Article in International journal for equity in health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Gout, TikTok and misleading information: a content analysis.Rheumatology advances in practice · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samuela OfanoaPacific Health Section, University of Auckland, 507, 28 Park Avenue, Grafton, Auckland, 1023, New Zealand. s.ofanoa@auckland.ac.nz.ORCID 0000-0001-9880-7176
Malakai OfanoaPacific Health Section, University of Auckland, 507, 28 Park Avenue, Grafton, Auckland, 1023, New Zealand.ORCID 0000-0003-2431-0399
Siobhan Tu'akoiPacific Health Section, University of Auckland, 507, 28 Park Avenue, Grafton, Auckland, 1023, New Zealand.ORCID 0000-0002-8955-1364
Hinamaha LutuiSouthpoint Family Doctors, Auckland, New Zealand.
Maryann HeatherPacific Health Section, University of Auckland, 507, 28 Park Avenue, Grafton, Auckland, 1023, New Zealand.ORCID 0000-0003-3629-2984
Felicity Goodyear-SmithDepartment of General Practice & Primary Health Care, University of Auckland, Auckland, New Zealand.ORCID 0000-0002-6657-9401

Funding

The Health Research Council of New Zealand 21/452
6 · The paper itself

Abstract

objectivesThis study aims to explore the views of Pacific people on how to improve the management of urate-lowering therapy among Pacific gout patients in South Auckland.

methodsThe study used the Fa'afaletui model to explore the views on gout management across different perspectives of Pacific community members and health professionals working in health providers with high Pacific patient populations. Three workshops were delivered with the community and health professionals. All data were collected by note-takers and analysed using a general inductive approach. Participants were given the opportunity to review the results of the previous workshop before starting the next one.

resultsThe key findings from this study clustered into three key themes: [1] Gout interventions guided by Pacific frameworks and research; [2] a multifaceted approach including education, improved access to treatment and screening for gout, and strategies to help Pacific gout patients remain engaged and adherent; and [3] Pacific gout champions.

conclusionThis study presents the views of community members of how to improve the uptake of urate-lowering therapy among Pacific gout patients. The community highlighted the need for a multifaceted intervention governed by a Pacific model, addressing access barriers and education for Pacific gout patients.

Indexed as

GoutGout SuppressantsUric AcidAdultFemaleHumansMaleMiddle AgedNew ZealandPerceptionGout SuppressantsUric AcidAccess to primary careCo-designCommunity participationEducationPacificUrate-lowering therapy

Identifiers

PMID40176052
PMCPMC11967122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.